{"id":42597,"date":"2025-10-21T13:15:27","date_gmt":"2025-10-21T12:15:27","guid":{"rendered":"https:\/\/www.hanitalenses.com\/?post_type=video&p=42597"},"modified":"2025-11-06T08:20:14","modified_gmt":"2025-11-06T08:20:14","slug":"first-clinical-outcomes-of-extend-hydrophobic-monoplus-dr-pavel-stodulka","status":"publish","type":"video","link":"https:\/\/www.hanitalenses.com\/de\/video\/first-clinical-outcomes-of-extend-hydrophobic-monoplus-dr-pavel-stodulka\/","title":{"rendered":"First Clinical Outcomes of Extend\u2122, Hydrophobic Monoplus – Dr. Stod\u016flka"},"content":{"rendered":"
In this ESCRS 2025 MedTalk, Dr. Pavel Stod\u016flka presents early clinical outcomes with Hanita Lenses‘ Extend\u2122 monofocal plus IOL. The lens features a hydrophobic, glistening-free material and a Bessel-beam optical concept designed to gently broaden depth of focus. Based on the initial series of 29 patients implanted with Extend\u2122 SL or Extend\u2122 Toric, he reports strong refractive accuracy along with dependable intermediate visual performance.<\/p>\n